Li, A.;                     Chen, J.-Y.;                     Hsu, C.-L.;                     Oyang, Y.-J.;                     Huang, H.-C.;                     Juan, H.-F.    
        A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis. Pharmaceutics 2022, 14, 971.
    https://doi.org/10.3390/pharmaceutics14050971
    AMA Style
    
                                Li A,                                 Chen J-Y,                                 Hsu C-L,                                 Oyang Y-J,                                 Huang H-C,                                 Juan H-F.        
                A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis. Pharmaceutics. 2022; 14(5):971.
        https://doi.org/10.3390/pharmaceutics14050971
    
    Chicago/Turabian Style
    
                                Li, Albert,                                 Jhih-Yu Chen,                                 Chia-Lang Hsu,                                 Yen-Jen Oyang,                                 Hsuan-Cheng Huang,                                 and Hsueh-Fen Juan.        
                2022. "A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis" Pharmaceutics 14, no. 5: 971.
        https://doi.org/10.3390/pharmaceutics14050971
    
    APA Style
    
                                Li, A.,                                 Chen, J.-Y.,                                 Hsu, C.-L.,                                 Oyang, Y.-J.,                                 Huang, H.-C.,                                 & Juan, H.-F.        
        
        (2022). A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis. Pharmaceutics, 14(5), 971.
        https://doi.org/10.3390/pharmaceutics14050971